Want to see AU:DVL full AI Analyst Report?
DVL Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.07
Previous CloseN/A
Volume1.00M
Average Volume (3M)8.34M
Market Cap
AU$32.11M
Enterprise ValueAU$46.01M
Total Cash (Recent Filing)AU$4.95M
Total Debt (Recent Filing)AU$135.68K
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,235,028,400
10 Day Avg. Volume5,304,106
30 Day Avg. Volume8,343,384
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)3.65
Price to Sales (P/S)9.17
P/FCF Ratio-10.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Niche Wearable Sensor ProductdorsaVi’s integrated wearable sensor hardware and software serve clinical assessment, rehabilitation and workplace health. That focused product-market fit creates durable differentiation and sticky workflows with professionals, supporting steady demand and deeper clinical adoption over months.
Low Financial LeverageA very low debt-to-equity ratio reduces fixed interest obligations and preserves balance sheet flexibility. That limited leverage helps the company withstand operating losses and gives strategic optionality to fund product development or commercialization via equity rather than onerous debt.
Improving Gross Profit MarginAn improving gross margin indicates better unit economics or cost of goods sold control. If sustained, this creates a pathway to profitability as revenue stabilizes and operating expenses are optimized, improving long-term margin sustainability even without near-term revenue growth.
Bears Say
Declining Revenue TrendA multiyear decline in revenue reduces scale benefits, weakens commercial leverage, and lengthens the path to breakeven. Persistently falling top line undermines ability to absorb fixed costs, constrains reinvestment in sales and product, and increases reliance on external funding.
Persistent Negative ProfitabilitySustained negative profitability erodes equity and limits internal funding for growth. Continued losses mean management must materially improve margins or secure capital; otherwise long-term strategic initiatives and R&D spending are constrained by the need to address core profitability.
Negative Operating Cash FlowOngoing negative operating cash flow signals the business does not yet generate cash from core activities, creating reliance on financing. That cash burn limits runway for commercialization and R&D, raising the risk of dilution or spending cuts that could slow structural growth.
dorsaVi Limited News
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$32.11M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Aug 21, 2026 which is in 18 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 1,235,028,400 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
dorsaVi Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 95%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
―
20 days / 200 days
Momentum
363.63%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
210.78%
Trailing 12-Months
Company Description
dorsaVi Limited
dorsaVi Limited (ASX: DVL) is a digital health and medical technology company that develops wearable sensor technology and software to measure human movement and muscle activity. The company’s products are used to support clinical assessment and rehabilitation and to provide objective movement data for professionals in settings such as physiotherapy, occupational health, and related healthcare and workplace environments.
Technical Analysis
Catapult Group International
―
X2M Connect Limited
―
Vection Technologies Ltd.
―
Audeara Ltd.
―
Nanoveu Ltd.
―